At geriatric age, the genuine state loses regenerative potential
Regulatory and Legal Response In February 2025, the FDA declared that the shortage of semaglutide had been resolved, marking the end of the GLP-1 drug shortage
With increasing obesity rates and rising diabetes cases worldwide, demand for oral GLP-1 medications is expected to grow significantly
I started shots recently, with proper diet and activity Im down approximately 13 lbs in going into 4th week
There have been some concerns about the potential for increased risk of pancreatitis while taking GLP-1 medications since people who drink heavily are also at increased risk for pancreatitis, Hendershot says
Patients transferring from another weight-loss prescription program, even from a different telehealth platform or physician, may qualify with a BMI of 22 or higher